Reference no: EM133720015
Questions
1. Spider angiomas, palmar erythema, telangiectasias, gynecomastia, and testicular atrophy are suggestive of:
(a) Kidney disease (b) Liver disease (c) Heart disease (d) Neurological disease
2. Which of the following is considered a full opioid agonist?
(a) Methadone (b) Buprenorphine (c) Naltrexone (d) All of the above
3. Which medication can be abruptly stopped, without weaning, after successful treatment of opioid use disorder?
(a) Methadone (b) Buprenorphine (c) Naltrexone (d) All the above
4. Buprenorphine-naloxone should not be used in:
(a) Severe liver impairment (b) Hypertension (c) Depression (d) All the above
5. Which of the following regarding naltrexone is NOT true?
(a) It is an opioid agonist (b) The patient should not be withdrawing when the medication is started, as it may cause the patient to go into more severe withdrawal. (c) When starting naltrexone, it should be medically supervised to pick up on any withdrawal. (d) It can be given as an oral formulation or injection.